Tags: Drug.

Etrolizumab is a humanized monoclonal antibody designed for the treatment of inflammatory bowel disease.Etrolizumab was developed by Genentech.

ATC prefix
none
CAS number
1044758-60-2
FDA UNII code
I2A72G2V3J

Loading...

This page contains content from the copyrighted Wikipedia article "Etrolizumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.